Immatics Ptb Ratio vs Pfcf Ratio Analysis

IMTX Stock

USD 10.89 0.08 0.74%

Immatics financial indicator trend analysis is infinitely more than just investigating Immatics NV recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immatics NV is a good investment. Please check the relationship between Immatics Ptb Ratio and its Pfcf Ratio accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immatics NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Ptb Ratio vs Pfcf Ratio

Ptb Ratio vs Pfcf Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immatics NV Ptb Ratio account and Pfcf Ratio. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Immatics' Ptb Ratio and Pfcf Ratio is -0.63. Overlapping area represents the amount of variation of Ptb Ratio that can explain the historical movement of Pfcf Ratio in the same time period over historical financial statements of Immatics NV, assuming nothing else is changed. The correlation between historical values of Immatics' Ptb Ratio and Pfcf Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ptb Ratio of Immatics NV are associated (or correlated) with its Pfcf Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Pfcf Ratio has no effect on the direction of Ptb Ratio i.e., Immatics' Ptb Ratio and Pfcf Ratio go up and down completely randomly.

Correlation Coefficient

-0.63

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Pfcf Ratio

Most indicators from Immatics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immatics NV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immatics NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Sales General And Administrative To Revenue is likely to rise to 1.03 in 2024, whereas Tax Provision is likely to drop 0.00 in 2024.

	2021	2022	2023	2024 (projected)
Interest Income	5.7M	2.5M	13.8M	14.5M
Net Interest Income	3.9M	1.4M	13.0M	13.7M

Interest Income Net Interest Income

Immatics fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other
Total Assets		0.62	0.89	0.52	-0.01	0.92	-0.81	0.6	0.84	0.95	0.6	0.62	-0.68	0.79	0.87	0.83	0.97	-0.63	0.91	0.93	0.83	0.74	-0.77	0.84	0.94	0.7
Other Current Liab	0.62		0.54	0.63	-0.69	0.54	-0.47	0.49	0.51	0.42	0.31	0.77	-0.11	0.52	0.42	0.3	0.48	-0.26	0.57	0.64	0.61	0.72	-0.31	0.38	0.75	0.44
Total Current Liabilities	0.89	0.54		0.11	0.19	0.83	-0.9	0.74	0.76	0.95	0.58	0.61	-0.88	0.8	0.94	0.96	0.94	-0.74	0.97	0.94	0.84	0.65	-0.74	0.8	0.93	0.49
Total Stockholder Equity	0.52	0.63	0.11		-0.7	0.45	-0.1	0.07	0.42	0.23	0.17	0.42	0.25	0.31	0.12	-0.06	0.33	0.03	0.22	0.34	0.29	0.52	-0.19	0.24	0.4	0.63
Other Liab	-0.01	-0.69	0.19	-0.7		-0.01	-0.15	-0.09	-0.03	0.26	0.2	-0.38	-0.58	-0.08	0.25	0.44	0.17	-0.24	0.1	-0.03	-0.02	-0.24	-0.26	0.25	-0.08	-0.22
Net Tangible Assets	0.92	0.54	0.83	0.45	-0.01		-0.89	0.62	0.91	0.89	0.7	0.58	-0.65	0.78	0.85	0.78	0.91	-0.73	0.84	0.91	0.93	0.64	-0.86	0.84	0.87	0.64
Retained Earnings	-0.81	-0.47	-0.9	-0.1	-0.15	-0.89		-0.72	-0.7	-0.89	-0.58	-0.4	0.84	-0.76	-0.95	-0.88	-0.87	0.93	-0.91	-0.92	-0.87	-0.42	0.87	-0.87	-0.82	-0.3
Accounts Payable	0.6	0.49	0.74	0.07	-0.09	0.62	-0.72		0.56	0.67	0.04	0.5	-0.65	0.94	0.73	0.65	0.65	-0.66	0.8	0.83	0.56	0.26	-0.31	0.36	0.6	0.49
Other Assets	0.84	0.51	0.76	0.42	-0.03	0.91	-0.7	0.56		0.77	0.75	0.78	-0.51	0.7	0.66	0.7	0.8	-0.44	0.7	0.8	0.9	0.79	-0.67	0.62	0.82	0.8
Cash And Short Term Investments	0.95	0.42	0.95	0.23	0.26	0.89	-0.89	0.67	0.77		0.56	0.47	-0.88	0.82	0.97	0.95	0.99	-0.78	0.96	0.94	0.8	0.57	-0.81	0.88	0.89	0.56
Net Receivables	0.6	0.31	0.58	0.17	0.2	0.7	-0.58	0.04	0.75	0.56		0.52	-0.4	0.17	0.48	0.59	0.58	-0.35	0.43	0.48	0.84	0.71	-0.8	0.7	0.67	0.29
Common Stock Shares Outstanding	0.62	0.77	0.61	0.42	-0.38	0.58	-0.4	0.5	0.78	0.47	0.52		-0.2	0.54	0.36	0.44	0.52	-0.06	0.52	0.61	0.7	0.9	-0.25	0.24	0.75	0.71
Capital Surpluse	-0.68	-0.11	-0.88	0.25	-0.58	-0.65	0.84	-0.65	-0.51	-0.88	-0.4	-0.2		-0.68	-0.92	-0.96	-0.83	0.82	-0.86	-0.77	-0.61	-0.26	0.69	-0.75	-0.67	-0.22
Other Current Assets	0.79	0.52	0.8	0.31	-0.08	0.78	-0.76	0.94	0.7	0.82	0.17	0.54	-0.68		0.82	0.72	0.82	-0.67	0.88	0.92	0.63	0.4	-0.46	0.52	0.72	0.69
Other Stockholder Equity	0.87	0.42	0.94	0.12	0.25	0.85	-0.95	0.73	0.66	0.97	0.48	0.36	-0.92	0.82		0.94	0.95	-0.9	0.97	0.94	0.77	0.43	-0.82	0.88	0.84	0.39
Total Liab	0.83	0.3	0.96	-0.06	0.44	0.78	-0.88	0.65	0.7	0.95	0.59	0.44	-0.96	0.72	0.94		0.92	-0.76	0.92	0.86	0.77	0.52	-0.77	0.82	0.83	0.4
Total Current Assets	0.97	0.48	0.94	0.33	0.17	0.91	-0.87	0.65	0.8	0.99	0.58	0.52	-0.83	0.82	0.95	0.92		-0.74	0.95	0.95	0.81	0.63	-0.8	0.87	0.91	0.62
Common Stock	-0.63	-0.26	-0.74	0.03	-0.24	-0.73	0.93	-0.66	-0.44	-0.78	-0.35	-0.06	0.82	-0.67	-0.9	-0.76	-0.74		-0.81	-0.78	-0.65	-0.08	0.8	-0.82	-0.6	-0.07
Property Plant Equipment	0.91	0.57	0.97	0.22	0.1	0.84	-0.91	0.8	0.7	0.96	0.43	0.52	-0.86	0.88	0.97	0.92	0.95	-0.81		0.98	0.78	0.55	-0.71	0.8	0.9	0.51
Short Long Term Debt Total	0.93	0.64	0.94	0.34	-0.03	0.91	-0.92	0.83	0.8	0.94	0.48	0.61	-0.77	0.92	0.94	0.86	0.95	-0.78	0.98		0.84	0.6	-0.72	0.78	0.92	0.61
Property Plant And Equipment Net	0.83	0.61	0.84	0.29	-0.02	0.93	-0.87	0.56	0.9	0.8	0.84	0.7	-0.61	0.63	0.77	0.77	0.81	-0.65	0.78	0.84		0.73	-0.85	0.79	0.89	0.49
Current Deferred Revenue	0.74	0.72	0.65	0.52	-0.24	0.64	-0.42	0.26	0.79	0.57	0.71	0.9	-0.26	0.4	0.43	0.52	0.63	-0.08	0.55	0.6	0.73		-0.45	0.48	0.83	0.67
Net Debt	-0.77	-0.31	-0.74	-0.19	-0.26	-0.86	0.87	-0.31	-0.67	-0.81	-0.8	-0.25	0.69	-0.46	-0.82	-0.77	-0.8	0.8	-0.71	-0.72	-0.85	-0.45		-0.97	-0.74	-0.21
Cash	0.84	0.38	0.8	0.24	0.25	0.84	-0.87	0.36	0.62	0.88	0.7	0.24	-0.75	0.52	0.88	0.82	0.87	-0.82	0.8	0.78	0.79	0.48	-0.97		0.81	0.25
Non Current Assets Total	0.94	0.75	0.93	0.4	-0.08	0.87	-0.82	0.6	0.82	0.89	0.67	0.75	-0.67	0.72	0.84	0.83	0.91	-0.6	0.9	0.92	0.89	0.83	-0.74	0.81		0.58
Non Currrent Assets Other	0.7	0.44	0.49	0.63	-0.22	0.64	-0.3	0.49	0.8	0.56	0.29	0.71	-0.22	0.69	0.39	0.4	0.62	-0.07	0.51	0.61	0.49	0.67	-0.21	0.25	0.58

Click cells to compare fundamentals

Immatics Account Relationship Matchups

Immatics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	134.3M	254.6M	174.6M	407.8M	510.0M	298.3M
Other Current Liab	3.4M	9.6M	30.4M	26.3M	45.9M	25.2M
Total Current Liabilities	69.3M	60.6M	95.1M	106.5M	156.6M	94.4M
Total Stockholder Equity	(41.9M)	104.3M	24.1M	213.2M	225.1M	122.1M
Net Tangible Assets	(42.9M)	86.5M	22.7M	211.5M	243.3M	255.4M
Retained Earnings	(233.2M)	(462.3M)	(537.8M)	(500.3M)	(597.3M)	(627.2M)
Accounts Payable	4.9M	2.6M	11.6M	13.1M	7.7M	8.0M
Other Assets	1.3M	724K	636K	2.5M	2.9M	3.1M
Cash And Short Term Investments	119.4M	232.0M	145.1M	362.2M	425.9M	235.7M
Net Receivables	2.7M	2.9M	682K	1.1M	5.7M	6.0M
Other Current Assets	665K	787K	6.4M	13.8M	7.1M	5.4M
Other Stockholder Equity	190.9M	573.3M	565.2M	714.2M	823.2M	525.4M
Total Liab	175.1M	150.4M	150.6M	194.7M	284.9M	176.1M
Total Current Assets	124M	239.0M	152.2M	377.2M	449.4M	256.1M
Property Plant Equipment	8.0M	14.0M	20.5M	26.5M	30.5M	16.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Immatics NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immatics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immatics Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immatics Nv Stock:

How To Invest In Immatics

Details

Is Immatics Stock a good investment?

Details

What is Immatics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immatics NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Immatics Stock analysis

When running Immatics' price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.

	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Bonds Directory Find actively traded corporate debentures issued by US companies
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Volatility Analysis Get historical volatility and risk analysis based on latest market data

Is Immatics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics. If investors know Immatics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immatics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.29)

Revenue Per Share

0.67

Quarterly Revenue Growth

(0.58)

Return On Assets

(0.14)

Return On Equity

(0.44)

The market value of Immatics NV is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics' value that differs from its market value or its book value, called intrinsic value, which is Immatics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics' market value can be influenced by many factors that don't directly affect Immatics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Immatics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immatics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Immatics Ptb Ratio vs Pfcf Ratio Analysis

Ptb Ratio vs Pfcf Ratio

Ptb Ratio vs Pfcf Ratio Correlation Analysis

Correlation Coefficient

Ptb Ratio

Pfcf Ratio

Immatics fundamental ratios Correlations

Immatics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Immatics fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Immatics Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 0.99	Cash And Short Term Investments
Short Long Term Debt Total	+ 0.98	Property Plant Equipment
Total Current Assets	+ 0.97	Total Assets
Property Plant Equipment	+ 0.97	Total Current Liabilities
Other Stockholder Equity	+ 0.97	Cash And Short Term Investments
Property Plant Equipment	+ 0.97	Other Stockholder Equity

Cash	- 0.97	Net Debt
Total Liab	- 0.96	Capital Surpluse
Other Stockholder Equity	- 0.95	Retained Earnings
Other Stockholder Equity	- 0.92	Capital Surpluse
Short Long Term Debt Total	- 0.92	Retained Earnings
Property Plant Equipment	- 0.91	Retained Earnings